Topic Listing for ABBOTT MEDICAL OPTICS INC

Abbott Medical Optics Inc Abbott Merger
Abbott Not Meet Closing Conditions Result Failure Acquisition Accelerated Share Repurchase Arrangement
Acceptance Accounting Changes
Accounting Terms Accrued Expenses
Accrued Liabilities Other Current Acquired In-process Research Development
Acquisition Intralase Acquisition Pfizer Inc Surgical Ophthalmic Business
Acquisition Visx Incorporated Acquisition Visx Incorporated Advanced Medical Optics Inc
Acquisitions Financial Guidance Acrylic
Additional Benefit Payment Rules Additional Corporate Governance Information
Additional Covenants Additional Financial Highlights
Additional Foreign Currencies Additional Highlights
Additional Information Find Additional Licenses
Additional Operating Results Additional Representations Warranties Covenants Gsco
Adjunctive Technologies Lasik Adjusted Eps 2003 Meeting Previous Guidance
Adjusted Operating Income Administration Amendment Interpretation Plan
Administration Amendment Termination Administration Plan
Administrative Agent Proofs Claim Admissions Parties
Adoption Eitf 04-8 Adoption Femtosecond Laser Product Offering Slower Anticipated
Adoption Sfas 123r Advanced Medical Optics
Advanced Medical Optics Acquire Intralase Corp Advanced Medical Optics Amo
Advanced Medical Optics Announces Addition Robert Palmisano Board Advanced Medical Optics Announces Full-year 2006 Results
Advanced Medical Optics Announces Purchase Advanced Medical Optics Announces Settlement Alcon Patent Infringement
Advanced Medical Optics Board Directors Advanced Medical Optics Completes Acquisition Visx Incorporated
Advanced Medical Optics Inc Advanced Medical Optics Inc 401 Plan
Advanced Medical Optics Inc Amo Advanced Medical Optics Inc Announces Offering Senior Subordinated
Advanced Medical Optics Inc Prices 250 Senior Subordinated Advances Phacoemulsification
Advisory Fiduciary Responsibility Affiliate
Affirmative Covenants Agreement
Agreement Master Netting Defined 101 38a Bankruptcy Code Agreement Plan Merger
Agreement Plan Merger Between Visx Incorporated Vault Corporation Agreement Stockholder
Agreements Allergan Aimee Weisner
Alcon Matters Alcon Mfg Ltd Lab Inc Advanced Medical Optics
Alcon Patents Alcon Products
Alcon Representations Warranties Alcons Covenants Not Sue
Alcons Payment Alternative Discussions Shareholders
Alternative Merger Agreement Although Expect Acquisition Result Benefits Combined Not Realize
Amadeus Amended Employment Agreement
Amended Restated 2008 Amended Restated Change Control Agreement
Amendment Amendment Agreement Plan Merger
Amendment Employment Agreement Amendment Rights Agreement
Amendments Amendments Etc
Amo Announces Full 2007 Results Amo Equipment
Amo Forward-looking Statement Amo Laser Vision Correction Technology
Amo Patents Amo Products
Amo Representations Warranties Amos Covenants Not Sue
Analysis 2007 Named Executive Officer Compensation Analysis Named Executive Officer Compensation
Announcement Consummation Transactions Described Merger Agreement Negative Impact Annual Report
Anti-kickback Laws Anti-terrorism Law
Anti-terrorism Law Anti-money Laundering Anticipated Benefits Acquisition Intralase
Appendix Applicable Law
Application Funds Appointment Authority
Approve Amo 2004 Stock Incentive Plan Arbitrators Not Explain Reason Award
Array Assignment Agreement
Assurance Cooperation Implement Agreement Attendance Meetings
Attending Person Audit Finance Committee
Auditor Independence Authorization Contravention
B5-1 Plan Counterparty Represents Warrants Covenants Gsco Each Baerveldt
Baerveldt Blink Blink-n-clean Clariflex Complete Bank America
Base Salary Basis Presentation
Because Visxs Expenses Relatively Fixed Short Term Earnings Beneficial Owners Common Stock
Beneficial Ownership Reporting Compliance Benefits Package
Binding Effect Blink
Board Committee Meetings Director Responsibilities Board Directors
Board Directors Recommends Vote Nominees Bonus
Bonus Pool Differentiation Business Unit Function Bonus Pool Funding
Books Records Borrowings Conversions Continuations Loans
Bring Admission Ticket Meeting 2008 Not Mail Broaden Product Portfolio Enhance Ability Generate Efficiencies
Burdensome Agreements Business
Business Repositioning Costs Business Segment Information
Business Segments Business Subject Environmental Regulations
Business Subject Extensive Government Regulation Capital Expenditures
Capitalized Software Cash Equivalents
Cash Equivalents Marketable Securities Cataract Business Unit
Cataract Implant Cataract Implant Business
Cataract Implant Overview Cataract Implant Sales Overview
Cataract Implant Sales Rose 1523 5520 2007 Cataract Implant Sales Rose Percent 1277
Cataract Implant Sales Rose Percent 1317 Cataract Implant Sales Rose Percent 1402
Cataract Sales Rose 1243 Cataract Sales Rose 1294
Cataract Sales Rose 149 1445 Cataract Surgery
Cataract Treatment Cataracts
Caution Concerning Forward-looking Statements Cautionary Statement Regarding Forward-looking Statements
Ceeon Ceo Discussions
Certain Factors Trends Affecting Amo Business Certain Factors Trends Affecting Amo Businesses
Certain Relationships Certain Relationships Related Transactions
Certain Waivers Certificates Other Information
Certificates Stock Certifications
Change Control Change Control Agreement
Change Control Agreement Filed 101 Change Control Agreements
Change Control Agreements Other Executives Change Control Arrangements
Change Currency Change Nature Business
Changes Disagreements Accountants Accounting Financial Disclosure Changes Ibm Services
Changing Vote Choose Tender Notes Repurchase
Clariflex Complete Clinical Trial Process Required Obtain Regulatory Approvals Costly
Collateral Guarantee Matters Commercially Available End Users
Commitment Contingencies Commitments
Commitments Contingencies Committees Board Directors
Common Stock Comparison Cumulative Total Return
Compensation Chief Executive Officer Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Package
Compensation Philosophy Objectives Compensation Philosophy Strategy
Compensation Tables Competition
Complete Moistureplus Completion Acquisition Assets
Compliance Laws Composition Board Directors
Composition Certain Financial Statement Captions Comprehensive Income
Comprehensive Income Loss Computation Interest Fees Retroactive Adjustments Applicable Rate
Concentration Credit Risk Concentration Suppliers
Conditions Consummation Merger Conditions Credit Extensions
Conditions Effectiveness Conditions Merger
Conditions Offer Conduct Meetings Executive Sessions
Conduct Meetings-executive Sessions Conduct Significant Amount Sales Operations Outside United States
Confidential Settlement Agreement Confidentiality
Conflicts Interest Audits Consent Independent Registered Public Accounting Firm
Consents Consideration Corporate Performance
Consideration Individual Performance Consolidated Financial Statements
Construction Against Party Consultant Agreements Post Rady
Contact Lenses Continuing Food Drug Administration Regulation
Controls Procedures Convertible Senior Subordinated Notes
Convertible Senior Subordinated Notes Due 2023 Convertible Senior Subordinated Notes Due 2023 Existing
Convertible Senior Subordinated Notes Due 2024 Convertible Senior Subordinated Notes Due 2025
Convertible Senior Subordinated Notes Due 2025 1375 Convertible Senior Subordinated Notes Due 2026
Convertible Senior Subordinated Notes Due 2026 325 Convertible Senior Subordinated Notes Offering
Core Brand Strength Corporate Global Marketing
Corporate Governance Corporate Governance Guidelines
Corporate Governance Guidelines Code Ethics Corporate Staffs
Corporate Vice President General Counsel Secretary Correcting Refractive Error
Costs Costs Associated Exit Disposal Activities
Counterparts Counterparty Purchases
Covenant Guarantee Obligations Give Security Covenants
Creation Direct Financial Obligation Off-balance Sheet Arrangement Credit Agreement
Critical Accounting Policies Estimates Current Executives
Current Report Pursuant Securities Exchange Act 1934 Cusip 00763maf5 00763mag3
Cusip 00763maj7 00763mah1 Cusip 00763mak4 00763mal2
Custom Eye Trays Customer Responsibilities
Customer Satisfaction Customers
Customers Sales Marketing Damages
Data Death Benefit Distributions
Death Benefits Debt
Debt Restructuring Default
Deferral Accounts Deferral Elections
Defined Terms Definitions
Definitions Specific Licensing Provisions Delegation Duties
Demonstration Demo Bundled Equipment Departure Directors Certain Officers Election Appointment Compensatory
Description Business Designated Senior Indebtedness
Despite Subsidiaries Current Levels Indebtedness Incur Substantially Debt Determine Market Value Notes
Determining Fair Value Diplomax
Director Compensation Director Independence
Director Information Director Options
Directors Directors Continuing Office Term Expiring 2007
Directors Continuing Office Term Expiring 2008 Directors Continuing Office-term Expiring 2008
Directors Continuing Office-term Expiring 2009 Directors Executive Officers Advanced Medical Optics Inc
Directors Executive Officers Corporate Governance Disability
Disclosure Dismissal
Dispositions Dispute Resolution
Dividend Equivalents Dividends
Documents Incorporated Reference Douglas Post
Earnings Loss Per Share Earnings Per Share
Effective Date Effective Date Term Plan
Election Director Eligibility Participation
Embargoed Person Employee Incentive Committee
Employee Relations Employee Restricted Stock Grant
Employee Restricted Unit Grant Employee Retirement Savings Plans
Employee Stock Ownership Plan Esop Employee Stock Purchase Plans
Employees Consultants Others Breach Proprietary Information Agreements Competitive Employment Agreement
Employment Agreements Employment Retention Agreement
Enforcement Enrollment Participation
Entire Agreement Modification Waiver Entities Advanced Medical Optics Inc
Entry Material Definitive Agreement Environmental Compliance
Environmental Matters Environmental Matters Preparation Reports
Equipment Lease Arrangements Equity Compensation Plan Information
Equity Compensation Plans Approved Stockholders Equity Incentives
Erisa Compliance Estimates
Even Though Intralase Obtained Regulatory Approvals Required Complete Events Default
Evidence Debt Exact Name Registrant Specified Charter
Exchange Rates Currency Equivalents Excise Tax Gross-up
Exculpatory Provisions Executive Benefits Payments Termination
Executive Compensation Executive Deferred Compensation
Executive Deferred Compensation Plan Executive Officers
Exhibits Existence Qualification Power Compliance Laws
Expense Expenses Indemnity Damage Waiver
Experience Losses Due Product Liability Claims Recalls Corrections Experience Losses Increased Expenses Due Legal Proceedings
Explanatory Exposed Foreign Currency Risks International Operations Adversely Affect
Express Reservation Rights Express Waiver Laws Limiting General Releases
Eye Care Eye Care Business Unit
Eye Care Manufacturing Update Eye Care Market
Eye Care Overview Eye Care Product Line
Eye Care Products Eye Care Recall
Eye Care Recalls Eye Care Sales
Eye Care Sales Declined 489 Percent 422 Eye Care Sales Declined 505 346 1710 2007
Eye Care Sales Declined 590 Eye Care Sales Declined 725 Percent 190
Eye Care Sales Overview Eye Care Sales Rose 191 502
Eye Care Sales Rose 2028 576 Eye Care Sales Rose Percent 593
Face Intense Competition Failure Compete Effectively Material Adverse Fail Attract Hire Retain Qualified Personnel Not Able
Fail Maintain Relationships Health Care Providers Customers Not Failure Party Financing Entities Satisfy Obligations Negatively Impact
Failure Party Financing Entities Satisfy Obligations Visx Negatively Failure Third-party Financing Entities Satisfy Obligations Negatively Impact
Fair Value Financial Instruments Fair Value Measurement
Fees Financial Covenants
Financial Guidance Financial Hardship Withdrawals
Financial Highlights Financial Instruments
Financial Statements Financial Statements Exhibits
Financial Statements Material Adverse Effect Find Additional Information Proposed Acquisition
Footnotes Following Page Foreign Currency Borrowings
Foreign Currency Fluctuations Foreign Currency Translation
Foreign Exchange Risk Management Form 10-k
Form 10-q Form Bonuses
Form Performance Award Agreement Form Repurchase Notice
Former Chairman William Grant Remains Member Board Former Executives
Former Name Address Changed Since Last Report Forward-looking Statements
Francine Meza Fraud Abuse
Full 2004 Results Full-year 2007 Results
Full-year 2007 Sales Performance Business Full-year 2008 Results
Fund Media Fundamental Changes
Funding Losses Funding Trigger Elements
Further Assurances Gaap Non-gaap Reconciliation
General General Administrative
General Economic Conditions Had Continue Negative Impact Business General Economic Conditions Negative Impact Business Financial Position
General Economic Conditions Negative Impact Visxs Business Financial General Indemnification
General Information General Limitation Guaranteed Obligations
General Provisions Generally Manufacture Cataract Implant Laser Vision Correction Products
Generally Manufacture Cataract Laser Vision Correction Products Single Generally Not Long-term Contracts Customers
Generally Not Long-term Contracts Customers Revenues Lasik Concentrated Geographic Area Information
Glaucoma Implant Global Sales
Global Scope Goldman Sachs Broad Street New York 10004 Tel
Goodwill Goodwill Intangible Assets Long-lived
Goodwill Long-lived Assets Governing Law Agreement Shall Governed Construed Accordance Laws
Governing Law Jurisdiction Consent Service Process Governmental Authorization Other Consents
Governmental Regulation Governmental Reimbursement
Greater Ease Practitioners Gross
Gross Margin Gross Profit
Guarantee Guarantee Payment Continuing
Hand Headings
Healon Healon5
Health Care Provider Customer Uncertainties Related Proposed Acquisition Health Care Providers Customers Not Continue Support Products
Hedging Heidrich
Herefore Amo Consultant Agree Follows Holders
Holders Tender Through Dtc Need Not Submit Physical Holders Withdraw Through Dtc Need Not Submit Physical
Holger Heidrich Phd Human Resources
Hydrogen Peroxide-based Solutions Hydrogen Peroxide-based Solutions Offer Products Disinfection Systems Leading
Illegality Immed Iate Release
Immediate Release Implantation Systems
Implementing Product Rationalization Repositioning Plan Require Significant Financial Important Information
Important Notice Regarding Availability Proxy Materials In-process Research Development
In-process Research Development Iprd In-service Distributions
Inability Determine Rates Incentive Compensation
Income Income Taxes
Increase Revolving Credit Facility Increased Cost Reduced Return Capital Adequacy Reserves Eurocurrency
Incremental Term Loans Indebtedness
Indebtedness After Acquisition Intralase Adversely Affect Cash Flows Indemnification
Indemnification Breach Representations Warranties Indemnities
Indenture Independence
Independent Auditor Fees Independent Registered Public Accounting Firm Independence
Index Index Financial Statements
Individual Bonus Award Calculation Industry
Inflation Information
Information Available Website Inject-o-ring
Injunctive Relief Inspection Rights
Instrument Payment Money Insurance
Intangible Assets Net Intangibles
Integration Intellectual Property Licenses Etc
Intense Competition Laser Vision Correction Industry Result Loss Intentionally Left Blank
Interest Interest Rate Limitation
Interest Rate Risk Interest Rate Risk Management
Internal Control Integrated Framework Internal Control Over Financial Reporting
International Regulation Interrelationship Compensation Elements
Intralase Acquisition Intralase Corp
Intralase Technology Intraocular Lenses
Introduction Inventories
Investments Iols
Irrigating Solutions Issuer Purchases Equity Securities
Jane Rady Judgment Currency
Labor Matters Lambert
Laser Vision Correction Laser Vision Correction Business
Laser Vision Correction Lvc Laser Vision Correction Lvc Overview
Laser Vision Correction Lvc Sales Overview Laser Vision Correction Lvc Sales Rose 912 Percent
Laser Vision Correction Lvc Sales Rose 954 Percent Laser Vision Correction Lvc Sales Rose 968 1017
Laser Vision Correction Lvc Sales Rose Percent 646 Laser Vision Correction Not Broadly Accepted Doctors Patients
Lasik Lasik Surgeons Not Adopt Femtosecond Laser Product Offering
Leadership Responsibilities Lease Commitments
Legal Proceedings Lens Rewetting Solutions
Leonard Borrmann Pharmd Letter Credit Amounts
License Alcon License Amo
Liens Liquidity
Liquidity Capital Resources List
Litigation Live Web Cast Audio Replay
Live Webcast Audio Replay Live Webcast Replay
Loans Long-term Incentives
Long-term Receivables Loss Per Share
Lower 2008 Guidance Maintenance Insurance
Maintenance Properties Major 2005 Developments
Major Customers Major Financial Developments
Management Bonus Program Managements Discussion Analysis Financial Condition Results Operations Visx
Mandatory Prepayments Manufacturing Capacity Not Adequate Meet Demands Business
Manufacturing Components Raw Materials Manufacturing Operations Facilities
Margin Regulations Investment Act Marked Signed Returned Direction Card
Marked Signed Returned Proxy Card Market Information
Market Registrants Common Equity Related Stockholder Matters Issuer Market Visx Operates Subject Extensive Government Regulation Increases
Marketing Sales Distribution Mason Morfit Board Directors
Material Contractual Obligations Matters Applicable Requests Compensation
Mazzo Measures Take Ensure Collection Femtosecond Laser Per Procedure
Measures Take Ensure Collection Laser Per Procedure Charges Mediation
Meetings Stockholders Meier
Memorandum Modified Amended Only Writing Signed Signatories Hereto Memorandum Shall Binding Inure Benefit Parties Respective Agents
Memorandum Understanding Merger
Merger Abbott Merger Transaction Means Acquisition Similar Involving Recapitalization Contemplated
Microkeratomes Miscellaneous
Miscellaneous Provisions Monofocal Lenses
Much Offering Pay What Form Payment Multi-purpose Solutions
Multifocal Refractive Lenses Name Person Filing Proxy Statement Other Registrant
Named Executive Officer Compensation Need Anything Not Wish Tender Notes Repurchase
Negative Covenants Net Debt Reduction
Net Earnings Net Earnings Loss
Net Gain Legal Contingencies Net Sales
Net Sales Product Line New Accounting Pronouncements
New Accounting Standards New Plan Benefits
Nine-month Financial Results Nominees Election Directors Term Expiring 2009
Nominees Election Directors-term Expiring 2010 Non-agency
Non-gaap Measures Non-operating Expense
Non-reliance Administrative Agent Other Lenders Non-us Holders
Nonqualified Stock Option Grant Not Applicable
Not Applicable Former Name Address Changed Since Last Not Introduce New Commercially Successful Products Timely Manner
Not Successfully Make Integrate Acquisitions Enter Strategic Alliances Notes Consolidated Financial Statements
Notes Currently Convertible Notes Pro Forma Condensed Combined Statement Operations
Notes Pro Forma Condensed Statement Operations Notice Annual Meeting Stockholders
Notices Notices Effectiveness Electronic Communication
Now Therefore Objectives
Obligations Unconditional Off-balance Sheet Arrangements
Offer Being Financed Offer Expire
Offer Letter Dated 2007 Was Entered Between Advanced Offering Repurchase Notes
Office Counterparty Each Transaction 170 East Andrew Place Officers
Offices Onsultant Greement
Operating Operating Income
Operating Procedures Ophthalmic Surgical
Ophthalmic Surgical Products Market Ophthalmic Surgical Sales
Optiedge Option Exercises Stock Vested
Option Grants Employees Consultants Organization Compensation Corporate Governance Committee
Other Assets Other Business
Other Cataract Surgical Related Products Other Comprehensive Income
Other Comprehensive Income Loss Other Consideration
Other Duties Etc Other Events
Other Financial Information Other Information
Other Interpretive Provisions Other Surgical Products
Other Terms Conditions Outstanding Shares
Overview Oxysept Step Rezoom
Page Part
Part Ii-other Information Part Other Information
Participants Parties Agree Amend Agreement Adding New Thereto Follows
Patent Assignment Patent Technology Assets
Patents Trademarks Other Intellectual Property Paying Agent
Payment Bonuses Payment Obligations Taxes
Payment Schedule Invoices Payments Generally Administrative Agents Clawback
Payments Ibm Payments Set Aside
Pending Acquisition Intralase Pending Acquisition Intralase Corp
Pending Acquisition Visx Incorporated Pension Benefit Plans
Pension Benefits People Needing Special Assistance
Perfection Security Interests Performance Award Certificate
Performance Awards Performance Business
Performance Objective Performance Product Line
Performance-based Awards Peter Nolan
Pfizer Inc Surgical Ophthalmic Business Phacoemulsification Systems
Plan Plan Reduce Fixed Costs
Policy Regarding 162 Possibility Long-term Side Effects Adverse Publicity Regarding Laser
Post Post-closing Matters
Potential Payments Termination Change-in-control Ppendix
Pre-approval Services Provided Independent Public Accountant Pre-approval Services Provided Independent Registered Public Accounting Firm
Pre-tax Charges Related Restructurings Transactions Recapitalizations Forfeiture Stock Preliminary Statements
Prepayments Etc Subordinated Indebtedness Presently Unknown Side Effects Related Femtosecond Laser Emerge
Preservation Existence Etc Principal Accountant Fees Services
Pro Forma Condensed Combined Financial Information Pro Forma Condensed Combined Statement Operations
Pro-forma Disclosures Sfas 123 Periods Prior 2006 Proceeds
Product Rationalization Business Repositioning Product Rationalization Business Repositioning Plan
Product Rationalization Business Repositioning Plan Recall Product Rationalization Business Repositioning Plan Recalls
Product Rationalization Repositioning Plan Product Recall
Product Recalls Product Update
Products Project Staff
Promptly Notify Gsco Following Such Announcement Been Properties
Property Liens Property Plant Equipment
Proposal Proposed 2008 Amendment Restatement
Proposed Acquisition Intralase Not Completed Incurred Substantial Costs Proposed Merger Abbott Not Completed Incurred Substantial Costs
Proposed Merger Abbott Not Completed Need Revisit Efforts Provisions Merger Agreement Deter Alternative Business Combinations Negatively
Proxies Work Proxy Solicited Behalf Board Directors
Purchase Agreement Purchase Technology
Purchases Allergan Purchases Equity Securities Issuer
Purpose Purpose Eligibility
Pursuant Pursuant Securities Exchange Act 1934
Quest Vision Technology Inc Questions
Quorum Rady
Raises 2006 Adjusted Eps Guidance Reaffirms 2007 Ratio Earnings Fixed Charges
Rationalization Repositioning Rationalization Repositioning Initiative
Rationalization Repositioning Strategy Raw Materials
Re-approve Amo 2002 Bonus Plan Reaffirms 2007 2008 Financial Guidance
Reaffirms Guidance Receipt Administrative Agent Following
Recent Accounting Standards Recent Acquisition Visx Incorporated
Recent Changes Accounting Treatment Stock Options Expected Negative Recent Sales Unregistered Securities
Recently Adopted Issued Accounting Standards Recently Issued Accounting Standards
Recitals Reclassification
Redeemable Convertible Preferred Stock Reducing Posterior Capsular Opacification Pco Following Cataract Surgery
References Agreements Laws Refractive Business Unit
Refractive Disorders Refractive Sales Declined 144 960
Refractive Sales Rose 1183 Refractive Sales Rose 555 1205 Pro Forma
Refractive Surgery Refractive Vision Correction
Refractive Vision Disorders Regions Business Units Global Marketing
Registrants Telephone Number 714 247-8200 Registrants Telephone Number Including Area Code 714 247-8200
Registration Rights Agreement Regular Registered Certified Mail
Regulation Regulation Disclosure
Reinstatement Related Parties
Related Party Transaction Related Party Transactions
Release Alcon Release Amo
Release Guarantors Reliance Administrative Agent
Reliance Patents Proprietary Technology Rely Certain Suppliers Manufacturers Raw Materials Other Products
Remainder Page Intentionally Left Blank Remedies
Remedies Event Default Repatriation Relocation Loan
Repayment Loans Replacements Lenders Certain Circumstances
Report Audit Finance Committee Report Independent Registered Public Accounting Firm
Report Organization Compensation Corporate Governance Committee Reported Gaap Net Loss 4381 953 Per
Reported Gaap Net Loss 4532 828 Per Repositioning Costs
Representations Warranties Representations Warranties Parent Merger Sub
Representations Warranties Parent Purchaser Repurchase 500 Common Stock
Required Satisfy Certain Indemnification Obligations Allergan Not Able Research Development
Research Development Regulatory Resignation Administrative Agent
Responsible Federal Income Tax Liabilities Relate Distribution Common Restatement
Restoring Accommodation Following Cataract Surgery Restricted Payments
Restricted Stock Restricted Stock Retention Grant
Restricted Stock Units Restrictive Covenants
Restrictive Covenants Other Provisions Restructuring Activities
Restructuring Plan Restructuring Update
Results Results Operations Financial Condition
Results Revised Guidance Retirement Benefit Distributions
Retirement Benefits Revenue
Revenue Recognition Accounts Receivable Revenues
Revised Financial Guidance Rezoom
Richard Meier Right Contribution
Right Designate Directors Rights Lender
Rights Plan Participants Risk Factors
Risks Relating Business Risks Relating Indebtedness Common Stock
Risks Relating Visxs Business Robert Gallagher
Role Board Directors Rounding
Rules Arbitration Forum Claim Filed Amendments Thereto Shall Russell Trenary
Sale Leaseback Transactions Sales Increase 2005
Sales Marketing Sales Overview Business
Sales Product Line Santa Ana 92705
Santa Ana Calif Feb 2009 Santa Ana Calif Friday Feb 2009 8211
Santa Ana Calif Jan 2009 Savings Investment Plan
Savings Retirement Benefits Schedule
Schedule 201 Schedule Parties Employment Agreement
Scheduled In-service Withdrawals Schedules
Science Technology Committee Securities Exchange Act 1934
Securities Registered Pursuant Act Securities Subject Plan
Security Ownership Certain Beneficial Owners Management Security Ownership Directors Executive Officers
Segment Reporting Selling General Administrative
Senior Credit Facility Senior Indebtedness
Senior Subordinated Notes Due Senior Subordinated Notes Due 2017
Separation Allergan Service Indebtedness Require Significant Amount Cash Ability Generate
Service Levels Service Locations
Set-off Severability
Severance Arrangements Severance General Release Agreements Messrs Post Trenary Rady
Sga Expense Share-based Compensation Expense
Shareholder Suit Sharing Payments Lenders
Sheree Aronson Signature
Signatures Signed Original Written Statement Required 302 Been Provided
Significant Accounting Policies Significant Accounting Policies Estimates Judgments New Pronouncements
Significant Amount Debt Agreements Contain Covenant Restrictions Limit Significant Amount Debt Substantial Indebtedness Adversely Affect Business
Silver Six-month Financial Results
Small Incision Surgery Software Proprietary Rights
Solicit Proxies Solvency
Some Debt Agreements Contain Covenant Restrictions Limit Ability Sovereign
Sovereign Compact Special Provisions Merger Transactions Notwithstanding Anything Contrary Herein
Speculative Transactions Stabileyes
Star Status Guidance
Stipulation Shall Include Among Other Things Following Provisions Stock
Stock Appreciation Rights Stock Asset Purchase Agreement Between Pfizer Inc Advanced
Stock Based Compensation Stock Incentive Plan
Stock Options Stock Ownership Guidelines
Stock Payments Stock Price Fluctuate Result Variety Factors Beyond Control
Stock-based Compensation Stock-based Compensation Expense
Stockholder Approval Stockholder Proposals Next
Stockholder Rights Plan Amended Restated Certificate Incorporation Bylaws Stockholders Equity
Strategic Business Units Strategic Rationale
Subject Intellectual Property Litigation Infringement Claims Cause Incur Submission Matters Vote Security Holders
Subrogation Subordination Subsequent Events
Successors Assigns Summary Bonus Plan
Summary Compensation Table Summary Significant Accounting Policies
Summary Term Sheet Supplemental Disclosures Noncash Transactions
Survival Survival Representations Warranties
Suspended Termination Date Shall Extended Each Scheduled Trading Suspension Calculation Period
Swing Line Loans Table Contents
Talk Questions Offer Tar
Tax Forms Taxes
Technology Services Agreement Technology Update
Tecnis Tecnis Multifocal
Tender Notes Tender Notes Receive Payment Them
Tender Support Agreements Term
Term Options Granted Independent Directors Shall Apply Solely Termination
Termination Amendment Waiver Termination Assistance
Termination Benefit Distributions Termination Benefits
Termination Employment Termination Reduction Commitments
Termination Result Death Disability Termination Without Cause Executive Good Reason
Terms Conditions Terms Nonqualified Stock Option Grants
Terms Performance Award Agreements Terms Restricted Stock Grants
Terms Restricted Unit Grants Third-party Beneficiaries
Times Timing Incentive Awards
Todays Live Web Cast Audio Replay Top Form
Transactions Affiliates Transition
Trenary Trends Contact Lens Care Market Negatively Impact Eye
Trust Insurance Contracts Types Awards
Unable Protect Intellectual Property Rights Business Prospects Harmed United States
United States Federal Income Tax Consequences United States Resident Federal Income Tax Purposes Pay
United States Securities Exchange Washington 20549 Unless Boxes Checked Trustee Refuse Register Notes Evidenced
Unregistered Sales Equity Securities Unregistered Sales Equity Securities Proceeds
Until What Time Withdraw Previously Tendered Notes Update Timeline Expected Merger Completion
Usa Patriot Act Notice Usc 1350
Vacating Delaware Judgment Veriflex
Verisyse Viscoelastics
Vision Impairment Vision Works
Visionkey Visx
Visx Acquisition Visx Fails Keep Pace Advances Industry Develop New
Visx Incorporated Visx Relies Small Number Customers Significant Portion Revenues
Visx Star Excimer Laser System Visx Treatment Cards
Visx Wavescan System Visxs Business
Visxs Business Dependent Enforceability Validity United States Foreign Visxs Employees Consultants Others Breach Proprietary Information Agreements
Visxs Reliance Sales International Markets Negatively Impact Revenues Visxs Single Source Suppliers Cease Providing Components Business
Vitrax Voluntary Prepayments
Voluntary Stock Option Cancellation Vote
Votes Needed Waiver Cumulative Remedies
Waiver Right Trial Jury Waivers
Warranty Obligations Wavefront Sciences Inc Wfsi
Wavescan Wavescan Whitestar
What Conditions Repurchase Notes What Notes Offering Repurchase
Whereas Whereas Counsel Amo Abbott Hand Plaintiffs Other Engaged
Whereas Defendants Produced Over 10500 Pages Documents Plaintiffs Whereas Plaintiffs Counsel Determined Settlement Action Terms Reflected
While Devote Significant Resources Research Development Not Lead While Visx Devotes Significant Resources Research Development Visxs
Whitestar Withdraw Previously Tendered Notes
Witnesseth World Wide Manufacturing
Xvii 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki